TORONTO, ON / June 22, 2022 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that its minority-owned subsidiary, Tech2Heal […]
Results show that oral cepharanthine plus paclitaxel (combination therapy) significantly reduced tumor volume and increased tumor growth inhibition at day 28, the final day of dosing compared to paclitaxel alone (p=0.0049) Dose range finding demonstrates […]
Vancouver, British Columbia–(Newsfile Corp. – June 9, 2022) – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics […]
SBT-272 improved neuronal health, superior to other approved and investigational agents Phase 1 study to evaluate safety and tolerability of SBT-272 in healthy volunteers is underway BOSTON, June 8, 2022 — Stealth BioTherapeutics Corp (NASDAQ: MITO), […]
Novavax COVID-19 vaccine receives positive vote from U.S. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee If Emergency Use Authorization is granted by the FDA, the Novavax COVID-19 vaccine would become the […]
Vancouver, British Columbia– June 7, 2022 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory […]
In Vivo Preclinical Data Expected to Enable Three New IND Applications to Evaluate Company’s Gamma Delta T cell Product Candidates Procel™, Isocel™, and Deltacel™ HOUSTON, June 07, 2022—-Kiromic BioPharma, Inc. (NASDAQ: KRBP), a clinical-stage biotherapeutics company […]
PDS Biotech has been granted Fast Track designation for PDS0101 in combination with KEYTRUDA® (pembrolizumab) for the treatment of recurrent or metastatic HPV16-positive head and neck cancer FLORHAM PARK, N.J., June 02, 2022 — PDS Biotechnology […]
Strengthens Patent Portfolio Protecting Horsepox-Based Live Virus Vaccines TNX-1840 and TNX-1850 are Potential RPV Vaccines Designed to Protect Against COVID-19 Confirms Leadership Position in Synthetic Biology Statutory Term of New Patent Expected to Provide Exclusivity […]
NEXT SUPER STOCK AI/ML Innovation (OTC: AIMLF) (CSE: AIML). Does this sub-$10 million market cap stock hold the key patents to the $15 Billion Health Monitoring Wearables Market? ABOUT THE EVENT NEXT SUPER STOCK Live! […]
Vancouver, British Columbia–( May 12, 2022 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory […]
– Enrollment Stopped Early for Efficacy – EXTON, Pa., May 17, 2022 — Idera Pharmaceuticals, Inc. (“Idera,” “we,” and “our”) (NASDAQ: IDRA) today shared positive interim results from Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands, […]
NEW YORK, May 12, 2022 — SIGA Technologies, Inc. (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the U.S. Department of Defense (DoD) awarded a contract to SIGA […]
Statistically significant inhibition of blood neutrophil elastase activity of up to 90% in patients in both high and low dose alvelestat groups throughout the 12-week dosing period Statistically significant reductions in the biomarkers Aα-val360 and desmosine […]
Phase 2A Microdose Clinical Study Capsules to be Manufactured VANCOUVER, BC, May 4, 2022 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
